Acorai is a medical device manufacturer of non-invasive intracardiac pressure monitoring to improve heart failure management.
Acorai has raised $4.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
Acorai's investors include European Innovation Council, Mayo Clinic, Capital Q® Ventures Inc., Golden Angels Investors, HealthTech Arkansas.
Acorai is headquartered in Helsingborg, Sweden.
Acorai is a medical device manufacturer of non-invasive intracardiac pressure monitoring to improve heart failure management.
Acorai is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Acorai — Funding & Investors." VCBacked, December 2, 2024, https://www.vcbacked.co/company/acorai. Accessed July 19, 2026.
VCBacked. (2024). Acorai — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/acorai
{{cite web |title=Acorai — Funding & Investors |url=https://www.vcbacked.co/company/acorai |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated